14.15
-0.05(-0.35%)
Currency In USD
| Previous Close | 14.2 |
| Open | 14.2 |
| Day High | 14.68 |
| Day Low | 14 |
| 52-Week High | 19.93 |
| 52-Week Low | 7.75 |
| Volume | 18,362 |
| Average Volume | 24,307 |
| Market Cap | 108.07M |
| PE | -2.28 |
| EPS | -6.2 |
| Moving Average 50 Days | 11.36 |
| Moving Average 200 Days | 14.23 |
| Change | -0.05 |
If you invested $1000 in Assembly Biosciences, Inc. (ASMB) 10 years ago, it would be worth $71.51 as of June 01, 2025 at a share price of $14.15. Whereas If you bought $1000 worth of Assembly Biosciences, Inc. (ASMB) shares 5 years ago, it would be worth $62.65 as of June 01, 2025 at a share price of $14.15.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Assembly Biosciences to Present During the Jefferies 2025 Global Healthcare Conference
GlobeNewswire Inc.
May 27, 2025 8:05 PM GMT
SOUTH SAN FRANCISCO, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral diseases, today announced that Jason Okazaki, chief executiv
New Preclinical Data for Assembly Biosciences’ Oral Hepatitis D Virus Entry Inhibitor ABI-6250 and Next-Generation Hepatitis B Virus Capsid Assembly Modulator ABI-4334 Presented at the EASL Congress 2025
GlobeNewswire Inc.
May 07, 2025 12:00 PM GMT
– Late-breaker poster highlights preclinical profile of ABI-6250, currently in Phase 1a with data anticipated in Q3 2025 – – Second poster describes in vitro studies of effects on viral infection markers by ABI-4334, currently in Phase 1b with data a
Assembly Biosciences Presents New Data Highlighting Long-Acting Herpes Simplex Virus Candidate ABI-5366 and Genital Herpes Prevalence and Treatment Patterns at the 2025 ESCMID Congress
GlobeNewswire Inc.
Apr 09, 2025 6:00 AM GMT
– Clinical and preclinical data supporting dosing profile and tolerability for ABI-5366, a novel long-acting helicase-primase inhibitor candidate, featured in two poster presentations – – Additional poster presentation highlights new insights in geni